PDT Partners’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
AVLSA
GC
ACM
PDT Partners's TECX Position: Q1 2022 in Review
PDT Partners sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 4,975 shares — an estimated $230K sold.
PDT Partners first reported a position in TECX in Q2 2021 and held it in 3 quarters. The position peaked at $501K in Q2 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.
- PDT Partners reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
- PDT Partners sold 4,975 Tectonic Therapeutic shares in Q1 2022, an estimated $230K.
- PDT Partners first reported a position in Tectonic Therapeutic in Q2 2021 and held it in 3 quarters.
- PDT Partners's Tectonic Therapeutic position peaked at $501K in Q2 2021.
- 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.
Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.